Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bcworld Pharm Co., Ltd. (200780:KRX), powered by AI.
Bcworld Pharm Co., Ltd. is currently trading at ₩3,590. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bcworld Pharm Co., Ltd. on Alpha Lenz.
Bcworld Pharm Co., Ltd.'s P/E ratio is -7.8.
“Bcworld Pharm Co., Ltd. trades at a P/E of -7.8 (undervalued) with modest ROE of -6.6%.”
Ask for details →Bcworld Pharm Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of a broad range of pharmaceutical products. Renowned for its commitment to innovation and quality, the company primarily focuses on creating pharmaceuticals that address critical healthcare needs. Bcworld Pharm Co., Ltd. engages in extensive research and development activities to produce prescription drugs, over-the-counter medications, and biopharmaceutical solutions. It plays a significant role in the healthcare sector by delivering products that enhance patient care and health outcomes. By leveraging cutting-edge technology and adhering to stringent regulatory standards, the company manages to maintain a strong presence in both domestic and international markets. With a robust portfolio tailored to suit diverse therapeutic areas, Bcworld Pharm Co., Ltd. continues to influence trends and advancements within the pharmaceutical landscape, positioning itself as a vital contributor to the global healthcare system.
“Bcworld Pharm Co., Ltd. trades at a P/E of -7.8 (undervalued) with modest ROE of -6.6%.”
Ask for details →Bcworld Pharm Co., Ltd. (ticker: 200780) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - General). It has approximately 284 employees. Market cap is $38.3B.
The current price is ₩3,590 with a P/E ratio of -7.82x and P/B of 0.54x.
ROE is -6.62% and operating margin is 2.63%. Annual revenue is $75.8B.